Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | adrenoceptor alpha 1A | Starlite/ChEMBL | References |
Rattus norvegicus | Alpha-1d adrenergic receptor | Starlite/ChEMBL | References |
Rattus norvegicus | Alpha-1b adrenergic receptor | Starlite/ChEMBL | References |
Homo sapiens | adrenoceptor alpha 1B | Starlite/ChEMBL | References |
Rattus norvegicus | Alpha-1a adrenergic receptor | Starlite/ChEMBL | References |
Homo sapiens | adrenoceptor alpha 1D | Starlite/ChEMBL | References |
Homo sapiens | 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | purine nucleoside phosphorylase | 0.0845 | 0.7544 | 0.7544 |
Trichomonas vaginalis | purine nucleoside phosphorylase I, putative | 0.1066 | 1 | 1 |
Brugia malayi | glutathione reductase | 0.0264 | 0.1082 | 0.0517 |
Treponema pallidum | purine nucleoside phosphorylase (deoD) | 0.0221 | 0.0596 | 0.5 |
Echinococcus multilocularis | purine nucleoside phosphorylase | 0.1066 | 1 | 1 |
Entamoeba histolytica | purine nucleoside phosphorylase, putative | 0.0221 | 0.0596 | 0.5 |
Schistosoma mansoni | methylthioadenosine phosphorylase | 0.0221 | 0.0596 | 0.0596 |
Toxoplasma gondii | thioredoxin reductase | 0.0264 | 0.1082 | 1 |
Schistosoma mansoni | uridine phosphorylase | 0.0221 | 0.0596 | 0.0596 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0264 | 0.1082 | 0.1082 |
Schistosoma mansoni | purine nucleoside phosphorylase | 0.1066 | 1 | 1 |
Echinococcus granulosus | purine nucleoside phosphorylase | 0.1066 | 1 | 1 |
Schistosoma mansoni | methylthioadenosine phosphorylase | 0.0221 | 0.0596 | 0.0596 |
Leishmania major | trypanothione reductase | 0.0264 | 0.1082 | 1 |
Echinococcus granulosus | purine nucleoside phosphorylase | 0.1066 | 1 | 1 |
Plasmodium falciparum | thioredoxin reductase | 0.0264 | 0.1082 | 1 |
Chlamydia trachomatis | AMP nucleosidase | 0.0221 | 0.0596 | 0.5 |
Echinococcus multilocularis | uridine phosphorylase 1 | 0.0221 | 0.0596 | 0.0596 |
Giardia lamblia | Purine nucleoside phosphorylase lateral transfer candidate | 0.1066 | 1 | 1 |
Schistosoma mansoni | amine GPCR | 0.082 | 0.7263 | 0.7263 |
Echinococcus multilocularis | purine nucleoside phosphorylase | 0.1066 | 1 | 1 |
Loa Loa (eye worm) | glutathione reductase | 0.0264 | 0.1082 | 0.1435 |
Entamoeba histolytica | purine nucleoside phosphorylase, putative | 0.0221 | 0.0596 | 0.5 |
Echinococcus granulosus | purine nucleoside phosphorylase | 0.1066 | 1 | 1 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0264 | 0.1082 | 0.1435 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0264 | 0.1082 | 0.1082 |
Echinococcus granulosus | purine nucleoside phosphorylase | 0.1066 | 1 | 1 |
Entamoeba histolytica | purine nucleoside phosphorylase, putative | 0.0221 | 0.0596 | 0.5 |
Mycobacterium tuberculosis | Probable purine nucleoside phosphorylase DeoD (inosine phosphorylase) (PNP) | 0.1066 | 1 | 1 |
Echinococcus granulosus | uridine phosphorylase 1 | 0.0221 | 0.0596 | 0.0596 |
Loa Loa (eye worm) | hypothetical protein | 0.0845 | 0.7544 | 1 |
Echinococcus granulosus | purine nucleoside phosphorylase | 0.1066 | 1 | 1 |
Echinococcus multilocularis | purine nucleoside phosphorylase | 0.1066 | 1 | 1 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0264 | 0.1082 | 1 |
Echinococcus multilocularis | purine nucleoside phosphorylase | 0.1066 | 1 | 1 |
Schistosoma mansoni | methylthioadenosine phosphorylase | 0.0221 | 0.0596 | 0.0596 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0264 | 0.1082 | 0.0517 |
Echinococcus granulosus | purine nucleoside phosphorylase | 0.1066 | 1 | 1 |
Treponema pallidum | uridine phosphorylase (udp) | 0.0221 | 0.0596 | 0.5 |
Echinococcus multilocularis | methylthioadenosine phosphorylase | 0.0221 | 0.0596 | 0.0596 |
Echinococcus multilocularis | purine nucleoside phosphorylase | 0.0845 | 0.7544 | 0.7544 |
Echinococcus granulosus | inosine guanosine and xanthosine phosphorylase | 0.0845 | 0.7544 | 0.7544 |
Onchocerca volvulus | Purine nucleoside phosphorylase homolog | 0.1066 | 1 | 0.5 |
Echinococcus multilocularis | purine nucleoside phosphorylase | 0.1066 | 1 | 1 |
Echinococcus granulosus | purine nucleoside phosphorylase | 0.1066 | 1 | 1 |
Loa Loa (eye worm) | uridine phosphorylase | 0.0221 | 0.0596 | 0.0791 |
Schistosoma mansoni | uridine phosphorylase | 0.0221 | 0.0596 | 0.0596 |
Echinococcus granulosus | methylthioadenosine phosphorylase | 0.0221 | 0.0596 | 0.0596 |
Entamoeba histolytica | MTA/SAH nucleosidase, putative | 0.0221 | 0.0596 | 0.5 |
Plasmodium vivax | glutathione reductase, putative | 0.0264 | 0.1082 | 1 |
Brugia malayi | Thioredoxin reductase | 0.0264 | 0.1082 | 0.0517 |
Schistosoma mansoni | purine nucleoside phosphorylase | 0.1066 | 1 | 1 |
Plasmodium falciparum | glutathione reductase | 0.0264 | 0.1082 | 1 |
Trypanosoma brucei | trypanothione reductase | 0.0264 | 0.1082 | 1 |
Treponema pallidum | pfs protein (pfs) | 0.0221 | 0.0596 | 0.5 |
Mycobacterium ulcerans | purine nucleoside phosphorylase | 0.1066 | 1 | 1 |
Entamoeba histolytica | purine nucleoside phosphorylase, putative | 0.0221 | 0.0596 | 0.5 |
Mycobacterium leprae | Probable purine nucleoside phosphorylase DeoD (INOSINE PHOSPHORYLASE) (PNP) | 0.1066 | 1 | 1 |
Entamoeba histolytica | purine nucleoside phosphorylase, putative | 0.0221 | 0.0596 | 0.5 |
Echinococcus granulosus | purine nucleoside phosphorylase | 0.1066 | 1 | 1 |
Loa Loa (eye worm) | S-methyl-5'-thioadenosine phosphorylase MTAP | 0.0221 | 0.0596 | 0.0791 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0264 | 0.1082 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0221 | 0.0596 | 0.5 |
Echinococcus multilocularis | purine nucleoside phosphorylase | 0.1066 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Kd (functional) | = 6.54 | Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor | ChEMBL. | 11931617 |
Kd (functional) | = 6.75 | Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor | ChEMBL. | 11931617 |
Kd (functional) | = 6.96 | Antagonistic affinity tested against isolated Rat Spleen Alpha-1B adrenergic receptor | ChEMBL. | 11931617 |
Kd (functional) | = 7.04 | Antagonistic affinity tested against isolated Rat Thoracic Aorta Alpha-1D adrenergic receptor | ChEMBL. | 11931617 |
Ki (binding) | = -9.29 | Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor | ChEMBL. | 11931617 |
Ki (binding) | = -8.2 | Affinity constant on CHO cells expressing Human recombinant 5-hydroxytryptamine receptor 1A | ChEMBL. | 11931617 |
Ki (binding) | = -7.91 | Affinity constant on CHO cells expressing Human recombinant Alpha-1B adrenergic receptor | ChEMBL. | 11931617 |
Ki (binding) | = -7.77 | Affinity constant on CHO cells expressing Human recombinant Alpha-1D adrenergic receptor | ChEMBL. | 11931617 |
Log Ki (binding) | = 7.77 | Affinity constant on CHO cells expressing Human recombinant Alpha-1D adrenergic receptor | ChEMBL. | 11931617 |
Log Ki (binding) | = 7.91 | Affinity constant on CHO cells expressing Human recombinant Alpha-1B adrenergic receptor | ChEMBL. | 11931617 |
Log Ki (binding) | = 8.2 | Affinity constant on CHO cells expressing Human recombinant 5-hydroxytryptamine receptor 1A | ChEMBL. | 11931617 |
Log Ki (binding) | = 9.29 | Affinity constant on CHO cells expressing Human recombinant Alpha-1A adrenergic receptor | ChEMBL. | 11931617 |
pA2 (functional) | = 6.54 | Antagonistic affinity tested against isolated Rat Prostate Alpha-1A adrenergic receptor | ChEMBL. | 11931617 |
pA2 (functional) | = 6.75 | Antagonistic affinity tested against isolated Rat Prostatic Vas Deferens Alpha-1A adrenergic receptor | ChEMBL. | 11931617 |
pA2 (functional) | = 6.96 | Antagonistic affinity tested against isolated Rat Spleen Alpha-1B adrenergic receptor | ChEMBL. | 11931617 |
pA2 (functional) | = 7.04 | Antagonistic affinity tested against isolated Rat Thoracic Aorta Alpha-1D adrenergic receptor | ChEMBL. | 11931617 |
Ratio (binding) | = 5 | Difference in antagonistic potency between functional and radioligand binding assay | ChEMBL. | 11931617 |
Ratio (binding) | = 9 | Difference in antagonistic potency between functional and radioligand binding assay | ChEMBL. | 11931617 |
Ratio (binding) | = 142 | Difference in antagonistic potency between functional and radioligand binding assay | ChEMBL. | 11931617 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.